BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Inflammatory disorder
,
Hippocampus
,
Pharmacogenetics
,
Doxorubicin
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vasodilators
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
FOS
PDE4B
ATF3
EGR1
CYP1A1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
PILON_KLF1_TARGETS_DN
heterocyclic compound binding
regulation of nitrogen compound metabolic process
PUJANA_BRCA1_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pulmonary artery smooth muscle gene expression before or after exposure to S-nitrosoglutathione
Rhabdomyosarcoma A673 cell treatments: Cytarabine, Doxorubicin and Puromycin
C3H10T1/2 Adipogenesis
Mouse cerebella from pups exposed to PTU to induce hypothyroidism
Differentiation of human pulmonary type 2 cells in vitro
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhaled pulmonary vasodilators: a narrative review.
In Vitro Drug Repurposing: Focus on Vasodilators.
Vasodilators activate TMEM16A channels in endothelial cells to reduce blood pressure.
Vasodilators mobilize SK3 channels in endothelial cells to produce arterial relaxation.
Vasodilators for primary Raynaud's phenomenon.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vasodilation Effect of Inhalational Anesthetics
Predictive Value of Vasodilator Challenge for Right Heart Failure After LVAD Implantation
Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output
Vasodilation in Patients With Fabry's Disease
Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ